Michael Evans
@mikeevans_ucsf
Chemical Biologist. Professor in the Departments of Radiology and Biomedical Imaging and Pharmaceutical Chemistry at UCSF
ID: 956933991747108865
26-01-2018 16:56:57
115 Tweet
336 Takipçi
286 Takip Edilen
Researchers at UC San Francisco have devised a new therapeutic strategy that could be used to treat a wide variety of cancers driven by mutations in the KRAS gene. Read press release: bit.ly/3MDUmjN Original study: bit.ly/34t17DD Adam Renslo Michael Evans UCSF School of Pharmacy
.Michael Evans received an American Cancer Society Mission Boost Grant to help move his research closer to patients. So encouraged by his team's new findings! Targeting the addiction to iron metabolism in KRAS-driven cancer.
Latest work with Rahul Aggarwal, Jim Wells, Felix Feng, Jonathan Chou, Ning Zhao and many other fantastic colleagues showing CDCP1 is a promising candidate for targeted radiotherapy in prostate cancer, including PSMA low/null disease. UCSF Imaging pubmed.ncbi.nlm.nih.gov/35604681/
CDCP1-surface membrane protein in #bladdercancer-expressed in 53%, no correlation with stage, metastatic site-highest in basal/squamous-expressed even in TROP2/NECTIN4-low cells-potential of theranostics seen preclinically Michael Evans prac.co/l/228u4bwv @practiceupdate
Exciting new study out of UCSF Helen Diller Family Comprehensive Cancer Ctr Michael Evans Jonathan Chou et al: Theranostic Targeting of CDCP1 in Multiple Subtypes of Bladder Cancer with Lu177 tinyurl.com/4tydrx87
.UCSF Imaging researchers from Dr. Michael Evans's (Michael Evans) lab & collaborators from UCSF School of Pharmacy, UCSF School of Medicine & UCSF Helen Diller Family Comprehensive Cancer Ctr evaluated CDCP1 expression in four bladder cancer #datasets. bit.ly/3mFtNlR
Congrats Jonathan Chou! Well deserved and look forward to seeing your project succeed.
We have developed a covalent nanobody that binds its target irreversibly via PERx. Using this nanobody as delivery vehicle for radionuclides enhances PET imaging and antitumor effects! Thanks to fantastic colleagues at UCSF. Paul Klauser Michael Evans pubs.acs.org/doi/10.1021/ac…
“These data establish for the first time that CDCP1 is expressed in bladder cancer and introduces a new therapeutic target for this common and deadly malignancy” UCSF Imaging's Dr. Shalini Chopra presented hopeful findings for targeting this devastating cancer at #SNMMI23
Honored and excited to be on SNMMI’s “Ones to Watch” list for 2023! Grateful for mentors, both past and present, for all the training, mentorship and opportunities in the field of nuclear medicine! Michael Evans UCSF Imaging Eszter Boros StonyBrookChem
.@UCSFImaging's Drs. Shalini Chopra, Kondapa Naidu Bobba, Youngho Seo, Rob Flavell, Michael Evans & collaborators unlock the potential of covalent protein radiopharmaceuticals in a new ACS Publications study. doi.org/10.1021/acscen…
CONGRATULATIONS to the Class of 2023 Prostate Cancer Foundation Young Investigator Awardees!!! 🥳🥳🥳👏👏👏🎉🎉🎉 We are so proud to fund these early career physicians and scientists who are committed to advancing the #ProstateCancer field!! pcf.org/c/the-prostate…
Extremely grateful and honored to receive the prestigious Prostate Cancer Foundation Young Investigator Award!! Thanks to mentors Michael Evans Craik Lab at UCSF Felix Feng for their constant support and mentorship! UCSF Imaging
Congratulations to UCSF Imaging's Dr. Michael Evans (Michael Evans) for being awarded SNMMI's Inaugural Sam Gambhir, MD Trailblazer Award! 👏 The Sam Gambhir Award recognizes outstanding achievement & excellence in transformative research & exceptional mentorship. #UCSFProud
UCSF Researchers Develop Precision Radiotherapy Approach for Cancer insideprecisionmedicine.com/topics/oncolog… via Inside Precision Medicine